{"id":"310","presentation":"14 - INSPIRE: Final Results from a Phase 3, Open-Label, Pivotal Study to Evaluate the Safety and Tolerability of LIQ861 in Pulmonary Arterial Hypertension","session":"SESSION 05 - ORAL: Pulmonary Hypertension: Where We're Going We Don't Need Roads","filename":"ISHLT 2020 ePresentation-14 N Hill et al vFinal 4-29-20.pptx","speaker":"N. Hill<small>, Boston, MA, United States of America<\/small>","photo":"","cover":"https:\/\/s3.us-west-2.amazonaws.com\/us-cslide-prod-presentations\/ishlt40th\/310\/jpg\/ishlt2020epresentation-14nhilletalvfinal4-29-20\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6671\/session_token\/0ff58a827d59695f425bfd62eabd7833","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]